한글목차

동물용 통증 관리 시장은 2023년부터 2028년에 걸쳐 8억 12만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 6.99%를 나타낼 것으로 예측됩니다.

동물용 통증 관리 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 반려동물 사육 증가에 의한 동물용 통증 관리 채택 증가, 동물 의료 시장의 지속적 진보, 고령화하는 반려동물 인구 증가에 대한 동물용 통증 관리 솔루션 채택 증가 등이 시장 성장을 촉진하고 있습니다.

본 조사에서는 향후 몇 년간 동물용 통증 관리 시장 성장을 가속하는 주요인 중 하나로서 멀티모달 통증 관리 접근 채택 증가를 들고 있습니다. 또한 동물의료에서의 원격의료 증가 경향, 식이보충제나 대체 요법에 대한 관심 증가는 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계

제3장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망(2023-2028년)

제4장 시장 규모 실적

• 세계의 동물용 통증 관리 시장(2018-2022년)
• 제품별 부문 분석(2018-2022년)
• 유통 채널별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 약물 : 시장 규모와 예측(2023-2028년)
• 디바이스 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 제품별

제7장 시장 세분화 : 유통 채널별

• 시장 부문
• 비교 : 유통 채널별
• 동물 병원 : 시장 규모와 예측(2023-2028년)
• 반려동물 케어 클리닉 : 시장 규모와 예측(2023-2028년)
• 약국 점포 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유통 채널별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Assisi Animal Health
• Bimeda Holdings Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Chanelle Pharma Group
• Dechra Pharmaceuticals Plc
• Durvet Animal Health Products
• Elanco Animal Health Inc.
• Manna Pro Products LLC
• Multi Radiance Medical
• Norbrook Laboratories Ltd.
• Vetoquinol SA
• Virbac Group
• Zoetis Inc.

제13장 부록

영문목차

The veterinary pain management market is forecasted to grow by USD 800.12 mn during 2023-2028, accelerating at a CAGR of 6.99% during the forecast period. The report on the veterinary pain management market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of veterinary pain management due to increasing pet ownership, ongoing advancements in veterinary medicine market, and rise in adoption of veterinary pain management solutions for growing geriatric pet population.

Technavio's veterinary pain management market is segmented as below:

By Product

• Drugs
• Devices

By Distribution Channel

• Veterinary hospitals
• Pet care clinics
• Pharmacy stores

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing adoption of multimodal pain management approaches as one of the prime reasons driving the veterinary pain management market growth during the next few years. Also, growing trend of telemedicine in veterinary care facilitates and rising interest in nutraceuticals and alternative therapies will lead to sizable demand in the market.

The report on the veterinary pain management market covers the following areas:

• Veterinary pain management market sizing
• Veterinary pain management market forecast
• Veterinary pain management market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading veterinary pain management market vendors that include Assisi Animal Health, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Durvet Animal Health Products, Elanco Animal Health Inc., Manna Pro Products LLC, Multi Radiance Medical, Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, and Zoetis Inc.. Also, the veterinary pain management market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global veterinary pain management market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global veterinary pain management market 2018 - 2022 ($ million)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.3 Distribution channel Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Drugs - Market size and forecast 2023-2028
• Exhibit 34: Chart on Drugs - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Drugs - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Drugs - Year-over-year growth 2023-2028 (%)
• 6.4 Devices - Market size and forecast 2023-2028
• Exhibit 38: Chart on Devices - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Devices - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Devices - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Devices - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Product
• Exhibit 42: Market opportunity by Product ($ million)
• Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 46: Chart on Comparison by Distribution Channel
• Exhibit 47: Data Table on Comparison by Distribution Channel
• 7.3 Veterinary hospitals - Market size and forecast 2023-2028
• Exhibit 48: Chart on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
• 7.4 Pet care clinics - Market size and forecast 2023-2028
• Exhibit 52: Chart on Pet care clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Pet care clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Pet care clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Pet care clinics - Year-over-year growth 2023-2028 (%)
• 7.5 Pharmacy stores - Market size and forecast 2023-2028
• Exhibit 56: Chart on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Pharmacy stores - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Pharmacy stores - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 60: Market opportunity by Distribution Channel ($ million)
• Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 Assisi Animal Health
• Exhibit 111: Assisi Animal Health - Overview
• Exhibit 112: Assisi Animal Health - Product / Service
• Exhibit 113: Assisi Animal Health - Key offerings
• 12.4 Bimeda Holdings Ltd.
• Exhibit 114: Bimeda Holdings Ltd. - Overview
• Exhibit 115: Bimeda Holdings Ltd. - Product / Service
• Exhibit 116: Bimeda Holdings Ltd. - Key offerings
• 12.5 Boehringer Ingelheim International GmbH
• Exhibit 117: Boehringer Ingelheim International GmbH - Overview
• Exhibit 118: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 119: Boehringer Ingelheim International GmbH - Key news
• Exhibit 120: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 121: Boehringer Ingelheim International GmbH - Segment focus
• 12.6 Ceva Sante Animale
• Exhibit 122: Ceva Sante Animale - Overview
• Exhibit 123: Ceva Sante Animale - Product / Service
• Exhibit 124: Ceva Sante Animale - Key offerings
• 12.7 Chanelle Pharma Group
• Exhibit 125: Chanelle Pharma Group - Overview
• Exhibit 126: Chanelle Pharma Group - Product / Service
• Exhibit 127: Chanelle Pharma Group - Key offerings
• 12.8 Dechra Pharmaceuticals Plc
• Exhibit 128: Dechra Pharmaceuticals Plc - Overview
• Exhibit 129: Dechra Pharmaceuticals Plc - Business segments
• Exhibit 130: Dechra Pharmaceuticals Plc - Key offerings
• Exhibit 131: Dechra Pharmaceuticals Plc - Segment focus
• 12.9 Durvet Animal Health Products
• Exhibit 132: Durvet Animal Health Products - Overview
• Exhibit 133: Durvet Animal Health Products - Product / Service
• Exhibit 134: Durvet Animal Health Products - Key offerings
• 12.10 Elanco Animal Health Inc.
• Exhibit 135: Elanco Animal Health Inc. - Overview
• Exhibit 136: Elanco Animal Health Inc. - Product / Service
• Exhibit 137: Elanco Animal Health Inc. - Key offerings
• 12.11 Manna Pro Products LLC
• Exhibit 138: Manna Pro Products LLC - Overview
• Exhibit 139: Manna Pro Products LLC - Product / Service
• Exhibit 140: Manna Pro Products LLC - Key offerings
• 12.12 Multi Radiance Medical
• Exhibit 141: Multi Radiance Medical - Overview
• Exhibit 142: Multi Radiance Medical - Product / Service
• Exhibit 143: Multi Radiance Medical - Key offerings
• 12.13 Norbrook Laboratories Ltd.
• Exhibit 144: Norbrook Laboratories Ltd. - Overview
• Exhibit 145: Norbrook Laboratories Ltd. - Product / Service
• Exhibit 146: Norbrook Laboratories Ltd. - Key offerings
• 12.14 Vetoquinol SA
• Exhibit 147: Vetoquinol SA - Overview
• Exhibit 148: Vetoquinol SA - Business segments
• Exhibit 149: Vetoquinol SA - Key news
• Exhibit 150: Vetoquinol SA - Key offerings
• Exhibit 151: Vetoquinol SA - Segment focus
• 12.15 Virbac Group
• Exhibit 152: Virbac Group - Overview
• Exhibit 153: Virbac Group - Business segments
• Exhibit 154: Virbac Group - Key news
• Exhibit 155: Virbac Group - Key offerings
• Exhibit 156: Virbac Group - Segment focus
• 12.16 Zoetis Inc.
• Exhibit 157: Zoetis Inc. - Overview
• Exhibit 158: Zoetis Inc. - Business segments
• Exhibit 159: Zoetis Inc. - Key news
• Exhibit 160: Zoetis Inc. - Key offerings
• Exhibit 161: Zoetis Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 162: Inclusions checklist
• Exhibit 163: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 164: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 165: Research methodology
• Exhibit 166: Validation techniques employed for market sizing
• Exhibit 167: Information sources
• 13.5 List of abbreviations
• Exhibit 168: List of abbreviations